Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

41,761 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
AI recognition of patient race in medical imaging: a modelling study.
Gichoya JW, Banerjee I, Bhimireddy AR, Burns JL, Celi LA, Chen LC, Correa R, Dullerud N, Ghassemi M, Huang SC, Kuo PC, Lungren MP, Palmer LJ, Price BJ, Purkayastha S, Pyrros AT, Oakden-Rayner L, Okechukwu C, Seyyed-Kalantari L, Trivedi H, Wang R, Zaiman Z, Zhang H. Gichoya JW, et al. Among authors: wang r. Lancet Digit Health. 2022 Jun;4(6):e406-e414. doi: 10.1016/S2589-7500(22)00063-2. Epub 2022 May 11. Lancet Digit Health. 2022. PMID: 35568690 Free PMC article.
Dual-functional antibiofilm polymer composite for biodegradable medical devices.
Chang CT, Chen YT, Hsieh YK, Girsang SP, Wang RS, Chang YC, Shen SH, Shen CR, Lin TP, Wan D, Wang J. Chang CT, et al. Among authors: wang j, wang rs. Mater Sci Eng C Mater Biol Appl. 2021 Apr;123:111985. doi: 10.1016/j.msec.2021.111985. Epub 2021 Feb 23. Mater Sci Eng C Mater Biol Appl. 2021. PMID: 33812613
Spatial interactions of immune cells as potential predictors to efficacy of toripalimab plus chemotherapy in locally advanced or metastatic pancreatic ductal adenocarcinoma: a phase Ib/II trial.
Cheng K, Li X, Lv W, Zhao G, Zhou R, Chang C, Yang H, Li R, Li Z, Chen Y, Yi C, Yan O, Xiao C, Zhang Y, Xiong J, Huang Z, Shao W, You X, Guo W, He D, Ling W, Wang R, Tian B, Zhao C, Cao D. Cheng K, et al. Among authors: wang r. Signal Transduct Target Ther. 2024 Nov 25;9(1):321. doi: 10.1038/s41392-024-02031-8. Signal Transduct Target Ther. 2024. PMID: 39582060 Free article. Clinical Trial.
Perioperative tislelizumab plus neoadjuvant chemotherapy for patients with resectable non-small-cell lung cancer (RATIONALE-315): an interim analysis of a randomised clinical trial.
Yue D, Wang W, Liu H, Chen Q, Chen C, Liu L, Zhang P, Zhao G, Yang F, Han G, Cheng Y, Yu B, Yang Y, Chen H, Jiang J, Tan L, Xu S, Mao N, Hu J, Zhang L, Yao B, Wang S, Wang RH, Zheng W, Wang C; RATIONALE-315 investigators. Yue D, et al. Among authors: wang rh. Lancet Respir Med. 2024 Nov 21:S2213-2600(24)00269-8. doi: 10.1016/S2213-2600(24)00269-8. Online ahead of print. Lancet Respir Med. 2024. PMID: 39581197
41,761 results
You have reached the last available page of results. Please see the User Guide for more information.